The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection Author Interview: Dr. Tsai, Tsen-Fang Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan DermatologistsBlog.com What are the main findings of the study? This study evaluated the safety of isoniazid (INH) prophylaxis for newly identified latent tuberculosis infection (LTBI) in patients [...]
All posts in category Ustekinumab – Stelara
Safety of ustekinumab (Stelara) in patients with moderate-to-severe psoriasis and latent tuberculosis infection
Posted by admin on July 20, 2012
http://dermatologistsblog.com/psoriasis/safety-of-ustekinumab-stelara-in-patients-with-moderate-to-severe-psoriasis-and-latent-tuberculosis-infection/
Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: Dr. Wolf
Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial. Author Interview Peter Wolf, MD Professor of Dermatology & Bioimmunotherapy Department of Dermatology Medical University of Graz Auenbruggerplatz 8 A-8036 Graz, Austria What are the main findings of the study? 311-nm narrowband UVB phototherapy significantly accelerated psoriatic lesion clearance in [...]
Posted by admin on January 12, 2012
http://dermatologistsblog.com/uv-light/treatment-with-311-nm-ultraviolet-b-enhanced-response-of-psoriatic-lesions-in-ustekinumab-treated-patients-dr-wolf/
Categories
Dermatology Author Interviews
Twitter
-
-
National Eczema Association
National Eczema Association
Pages
-
Dermatology Research Studies from NIH
Dermatology Meetings & Skin Care Events
June 2013 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 -
